Dive into the science of precision cancer medicine at Knight School

Targeted therapy drugs have transformed the outlook for people diagnosed with one form of blood cancer, chronic myeloid leukemia. A disease with a three- to five-year life expectancy became, for...

Help researchers understand Oregon’s cancer needs

A new survey from the OHSU Knight Cancer Institute aims to help researchers understand the cancer-related needs of Oregonians and inform ways to address those needs across the state. Figure:...

Bringing together the leaders in cancer early detection

The Early Detection of Cancer Conference is part of a long-term commitment to invest in early detection, to understand the biology behind early stage cancers, find new detection and screening...

Helping more bladder cancer patients preserve a functioning bladder

Knight Cancer clinicians at Tuality/OHSU Cancer Center are the first in Oregon to offer a treatment option that will improve outcomes for patients with bladder cancer who cannot tolerate surgery or...

Cancer cell fusion study showcased in Science

Cell fusion is one of the ways that tumors can gain abilities to become life-threatening and resist treatment, Melissa Wong, Ph.D., and colleagues first reported last year. The paper now is one of...

Targeting osteosarcoma, a cancer more common in young people

Knight Cancer researchers describe positive results with the drug regorafenib. Osteosarcoma is a bone cancer that disproportionately affects teenagers, and despite substantial efforts, outcomes for...